BioCentury
ARTICLE | Clinical News

Leptin: AMGN began an initial human trial in 100-200 patients to evaluate safety and tolerability of leptin

May 28, 1996 7:00 AM UTC

Amgen Inc. (AMGN), Thousand Oaks, Calif. Product: Leptin (OB) protein Indication: Obesity Status: AMGN began an initial human trial in 100-200 patients to evaluate safety and tolerability of leptin ac...